The lack of immunogenicity has practical implications: the peptide can be used for extended periods without loss of efficacy due to antibody neutralization, there is minimal risk of allergic or hypersensitivity reactions, and repeated treatment cycles are supported as prior exposure does not sensitize the immune system
In the body, IGF-1 can activate growth a multitude of bodily tissues, including the nerves, bone, kidneys, and liver
This includes the best ways to treat mild, severe, and dual deficiencies
AOD9604 is bioavailable orally, with MS peptide analysis confirming appearance in pig plasma following oral dosing, and degradation occurring primarily via sequential N-terminal amino acid removal in a cascade fashion
I had a blood test done and my b12 levels were 150
Effectiveness of Oral Form: There is a consensus that injectable AOD 9604 is far more effective than the oral form, which seems to have lower bioavailability